Financhill
Back

Seres Therapeutics Stock Price Chart

  • The current trend is relatively stagnant and MCRB is experiencing slight buying pressure.

Seres Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 5.46 Buy
20-day SMA: 5.38 Buy
50-day SMA: 5.85 Sell
200-day SMA: 5.3 Buy
8-day EMA: 5.45 Buy
20-day EMA: 5.46 Buy
50-day EMA: 5.77 Sell
200-day EMA: 6.26 Sell

Seres Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 48.63 Sell
Chaikin Money Flow: 213521 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.23 - 5.53) Buy
Bollinger Bands (100): (5.5 - 7.26) Sell

Seres Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Seres Therapeutics Stock

Is Seres Therapeutics Stock a Buy?

MCRB Technical Analysis vs Fundamental Analysis

Sell
43
Seres Therapeutics (MCRB) is a Sell

Is Seres Therapeutics a Buy or a Sell?

Seres Therapeutics Stock Info

Market Cap:
684.01M
Price in USD:
5.49
Share Volume:
896.79K

Seres Therapeutics 52-Week Range

52-Week High:
9.49
52-Week Low:
2.50
Sell
43
Seres Therapeutics (MCRB) is a Sell

Seres Therapeutics Share Price Forecast

Is Seres Therapeutics Stock a Buy?

  • Seres Therapeutics share price is 5.49 while MCRB 8-day exponential moving average is 5.45, which is a Buy signal.
  • The stock price of MCRB is 5.49 while Seres Therapeutics 20-day EMA is 5.46, which makes it a Buy.
  • Seres Therapeutics 50-day exponential moving average is 5.77 while MCRB share price is 5.49, making it a Sell technically.
  • MCRB stock price is 5.49 and Seres Therapeutics 200-day simple moving average is 6.26, creating a Sell signal.

Fundamental Analysis of Seres Therapeutics

Is Seres Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.11 per share, and an increase next year of $0.60 per share.

Technical Analysis of Seres Therapeutics

Should I short Seres Therapeutics stock?

* Seres Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.